NCT03100305 is a clinical trial of Collection of blood and urine in Premature Infant, sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

Who is sponsoring NCT03100305?

NCT03100305 is sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.

What drugs are being tested in NCT03100305?

Interventions in NCT03100305: Collection of blood and urine.

What condition does NCT03100305 study?

NCT03100305 studies Premature Infant.

Is NCT03100305 still recruiting?

NCT03100305 is currently completed. Last updated 3 April 2018.

Last reviewed 2018-04-03 · How we verify

NCT03100305

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Amino Acids Profiles in Premature Infants Receiving Nutritional Support

Completed Last updated 3 April 2018

What this trial tests

trial testing Collection of blood and urine in Premature Infant in 124 participants. Completed in 20 March 2018.

Timeline

1 January 2017

Primary endpoint
15 February 2018

20 March 2018

Quick facts

Lead sponsor	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status	Completed
Study type	OBSERVATIONAL
Enrollment	124
Start date	1 January 2017
Primary completion	15 February 2018
Estimated completion	20 March 2018
Sites	1 location across China

Drugs / interventions tested

Collection of blood and urine — full drug profile →

Conditions studied

Premature Infant — all drugs for Premature Infant →

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Who can join

Eligibility, any sex, with Premature Infant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the changes of amino acid metabolic profiles in different nutritional stages of preterm infants and determine the effects of nutritional intervention on the amino acid metabolic status of preterm infants.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Metabolic analysis of infants with bronchopulmonary dysplasia under early nutrition therapy: An observational cohort study.
Wang L, Zhong WH, Liu DY, Shen HQ, et al · · 2022 · cited 9× · PMID 34894806 · DOI 10.1177/15353702211060513
Analysis of Amino Acid Patterns With Nutrition Regimens in Preterm Infants With Extrauterine Growth Retardation.
Wang L, Liu D, Shen H, Wang Y, et al · · 2020 · cited 6× · PMID 32426308 · DOI 10.3389/fped.2020.00184

Verify or expand the search:

Other trials of Collection of blood and urine

Trials testing the same drug.

NCT04453917 — Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy · NA · completed

Other recruiting trials for Premature Infant

Currently open trials in the same condition.

NCT07410858 — Virtual Reality-Enhanced Parent Education in Neonatal Intensive Care · NA · recruiting
NCT07052786 — Development and Effectiveness Evaluation of a Clustered Care Guideline Within Individualized Developmental Care: RCT · NA · recruiting
NCT06212427 — Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs) · NA · recruiting
NCT07100353 — Premature Infants' Developmental Function, Daily Living, Participation, and Quality of Life: A Longitudinal Study · active not recruiting
NCT03825835 — 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants · NA · recruiting

Other Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials

Trials by the same sponsor.

NCT07506811 — Effects of Different Music Tempos on Feeding Outcomes in Preterm Infants · NA · not yet recruiting
NCT07441187 — Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type · not yet recruiting
NCT07375602 — A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children · recruiting
NCT07405658 — Clinical Study on an Artificial Intelligence-Assisted Chest Radiograph Model Based on Big Data and Deep Learning for Ear · not yet recruiting
NCT07381400 — Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Stu · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03100305 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Last refreshed: 3 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03100305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing